...
首页> 外文期刊>Journal of pharmaceutical investigation >Development and evaluation of film coated aceclofenac and chlorzoxazone tablet with enhanced dissolution rate
【24h】

Development and evaluation of film coated aceclofenac and chlorzoxazone tablet with enhanced dissolution rate

机译:溶出速率提高的薄膜包衣醋氯芬酸和氯唑沙宗片的研制与评价

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Out of many complications two major problems facing in formulation industry are poor solubility and short half-life of drugs which results into poor bioavailability after oral administration. Solid dosage forms are coated for a number of reasons, the most important of which is controlling the release profiles and bioavailability of the active ingredient. Thus the development of a significant dissolution procedure for drug products with limited water solubility has been a challenge to the pharmaceutical industry. Aceclofenac (Biopharmaceutical classification Class II drug) is a novel non-steroidal anti-inflammatory drugs (NSAIDs) having anti-inflammatory and analgesic properties, and is widely used in the treatment of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. The investigation revealed that there is no official dissolution medium available in the literature. The objective of present study is to formulate film coated tablet of Aceclofenac and Chlorzoxazone having short half-life by coating with hydroxyl propyl methyl cellulose (E5 LV). Then the formulated tablets were evaluated for its physicochemical properties and in vitro release studies. The incorporation of drugs into polymer matrices is considered a valid tool in order to optimize insufficient features of the drug molecule, like solubility, stability or toxic effects. In the present work, the incorporation of aceclofenac was performed in inert HPMC and there was no chemical interaction between the drug and polymers as concluded from the FTIR studies. In the present study, parameters such as solubility, medium pH, surfactant type, dissolution behavior of formulations, stability, and discriminatory effect of dissolution testing in different dissolution mediums were studied for the selection of a proper dissolution medium. The drug showed an enhanced release rate in the dissolution media containing pH 6.8 phosphate buffer, 900 ml with 0.5 % sodium lauryl sulphate at 75 rpm for 60 min and thus was chosen as the discriminating dissolution method for film coated aceclofenac formulation. It was found that greater than 80 % of the label amount is released over 60 min.
机译:在许多并发症中,制剂工业面临的两个主要问题是药物的溶解性差和半衰期短,这导致口服后生物利用度差。出于各种原因,将固体剂型包衣,其中最重要的是控制活性成分的释放曲线和生物利用度。因此,为水溶性有限的药物开发有效的溶解方法一直是制药工业的挑战。醋氯芬酸(生物药物分类II类药物)是一种具有抗炎和镇痛作用的新型非甾体类抗炎药(NSAID),广泛用于类风湿性关节炎,骨关节炎和强直性脊柱炎的治疗。调查显示,文献中没有可用的官方溶出介质。本研究的目的是通过用羟丙基甲基纤维素(E5 LV)包衣来配制半衰期短的醋氯芬酸和氯唑酮的薄膜包衣片剂。然后评估配制的片剂的理化性质和体外释放研究。为了优化药物分子的不足特征,例如溶解性,稳定性或毒性作用,将药物掺入聚合物基质被认为是有效的工具。在目前的工作中,醋氯芬酸的掺入是在惰性HPMC中进行的,并且从FTIR研究得出结论,药物与聚合物之间没有化学相互作用。在本研究中,为了选择合适的溶出介质,研究了诸如溶度,介质pH,表面活性剂类型,制剂的溶出行为,稳定性以及溶出度试验在不同溶出介质中的鉴别作用等参数。该药物在含有pH 6.8磷酸盐缓冲液,900 ml和0.5%月桂基硫酸钠的溶出介质中以75 rpm的转速显示60分钟的释放速率提高,因此被选作薄膜包衣醋氯芬酸制剂的区分溶出方法。发现在60分钟内释放了超过80%的标记量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号